Ridazolol

Ridazolol
Names
	IUPAC name 5-Chloro-4-[2-[[3-(2-chlorophenoxy)-2-hydroxypropyl]amino]ethylamino]-1H-pyridazin-6-one
Identifiers
3D model (Jmol)	Interactive image
ChEMBL	ChEMBL1742443
ChemSpider	64393
PubChem	71265
	InChI InChI=1S/C15H18Cl2N4O3/c16-11-3-1-2-4-13(11)24-9-10(22)7-18-5-6-19-12-8-20-21-15(23)14(12)17/h1-4,8,10,18,22H,5-7,9H2,(H2,19,21,23) Key: UUWABVCZFXKHSU-UHFFFAOYSA-N ; InChI=1/C15H18Cl2N4O3/c16-11-3-1-2-4-13(11)24-9-10(22)7-18-5-6-19-12-8-20-21-15(23)14(12)17/h1-4,8,10,18,22H,5-7,9H2,(H2,19,21,23) Key: UUWABVCZFXKHSU-UHFFFAOYAL ;
	SMILES C1=CC=C(C(=C1)OCC(CNCCNC2=C(C(=O)NN=C2)Cl)O)Cl ;
Properties
Chemical formula	C15H18Cl2N4O3
Molar mass	373.23 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	Infobox references

Ridazolol is a beta adrenergic receptor antagonist.^[1]

References[edit]

^ Fach, WA; Starke, E; Becker, HJ (1992). "Duration of the effect and dose-response relationship of ridazolol in patients with coronary heart disease". Zeitschrift für Kardiologie. 81 (6): 320–5. PMID 1353933.

This article about an organic compound is a stub. You can help Wikipedia by expanding it.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.